WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 4 fonti

Oral Small-Molecule Elecoglipron Tackles Obesity and Diabetes

Investigational pill was well-tolerated and doesn't come with food or water restrictions

Raccontata damorningstar.commedpagetoday.combenzinga.comindependent.co.uk

Confronto fonti

4 prospettive sulla stessa storia
AI · summaries
medpagetoday.comStai leggendo2 g fa

Oral Small-Molecule Elecoglipron Tackles Obesity and Diabetes

Investigational pill was well-tolerated and doesn't come with food or water restrictions

originale
morningstar.com3 g fa

Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results

Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results

Leggi questa versione → originale
independent.co.uk1 g fa

AstraZeneca daily pill shows promising weight loss results in trial

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be…

Leggi questa versione → originale
benzinga.com2 g fa

AstraZeneca's GLP-1 Pill Heads To Late-Stage Trials - AstraZeneca (NYSE:AZN)

AstraZeneca advances oral GLP-1 elecoglipron to Phase 3 following strong weight loss & diabetes data at ADA 2026. Get the trial details.

Leggi questa versione → originale

Timeline cronologica

  1. lunedì 8 giugno 2026·morningstar.com

    Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results

    Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results

  2. martedì 9 giugno 2026·medpagetoday.com

    Oral Small-Molecule Elecoglipron Tackles Obesity and Diabetes

    Investigational pill was well-tolerated and doesn't come with food or water restrictions

  3. martedì 9 giugno 2026·benzinga.com

    AstraZeneca's GLP-1 Pill Heads To Late-Stage Trials - AstraZeneca (NYSE:AZN)

    AstraZeneca advances oral GLP-1 elecoglipron to Phase 3 following strong weight loss & diabetes data at ADA 2026. Get the trial details.

  4. mercoledì 10 giugno 2026·independent.co.uk

    AstraZeneca daily pill shows promising weight loss results in trial

    Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…